Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-01-28 @ 6:27 PM
Study NCT ID:
NCT01563302
Status:
COMPLETED
Last Update Posted:
2018-06-25
First Post:
2012-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2, Open-label, Dose-escalation Study of IONIS-STAT3Rx, Administered to Patients With Advanced Cancers
Sponsor:
Ionis Pharmaceuticals, Inc.
Organization: